SCHEMBL9254569

SCHEMBL9254569

N#Cc1ccccc1-c1ccc(Cc2c(O)nc3ncnn3c2CO)cc1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ESR2 Q92731 1/20 0.40
PPARG P37231 2/20 0.38
GABRA1 P14867 1/20 0.37
GABRG2 P18507 1/20 0.37
GABRB3 P28472 1/20 0.37
GABRA2 P47869 1/20 0.37
EGLN1 Q9GZT9 1/20 0.36
MBOAT4 Q96T53 2/20 0.36
ENPP1 P22413 4/20 0.36
FFAR1 O14842 1/20 0.36
AKR1B1 P15121 1/20 0.36
CYP19A1 P11511 3/20 0.35
MME P08473 1/20 0.34
PRKAG1 P54619 1/20 0.34
PRKAA1 Q13131 1/20 0.34
PRKAB1 Q9Y478 1/20 0.34
EGLN2 Q96KS0 1/20 0.34
MYC P01106 1/20 0.34
WDR5 P61964 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9253827 0.92 PPARG (0.41) ESR2PPARGGABRA1GABRG2GABRB3
SCHEMBL7311768 0.90 PPARG (0.46) PPARGENPP1
SCHEMBL9254089 0.89 ESR2 (0.39) ESR2PPARGGABRA1GABRG2GABRB3
SCHEMBL9256663 0.89 PPARG (0.43) PPARG
SCHEMBL9256116 0.88 EGLN1 (0.46) ESR2PPARGGABRA1GABRG2GABRB3
SCHEMBL9253540 0.88 USP2 (0.42) ESR2PPARGGABRA1GABRG2GABRB3
Diethylamine SCHEMBL9256272 0.87 PPARG (0.44) PPARGENPP1
SCHEMBL9249469 0.82 ENPP1 (0.47) GABRA1GABRG2GABRB3GABRA2MBOAT4
SCHEMBL9254113 0.80 PPARG (0.39) ESR2PPARGGABRA1GABRG2GABRB3
SCHEMBL9250470 0.79 SLC33A1 (0.45) PPARGENPP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5387747-A Used in the treatment and prevention of cardiovascular diseases: hypertension, cardiac insufficiency and atherosclerosis LABORATOIRES UPSA (FR) 1995-02-07 US disclosed